These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 21480436)

  • 21. C-terminal amidation of PMAP-23: translocation to the inner membrane of Gram-negative bacteria.
    Kim JY; Park SC; Yoon MY; Hahm KS; Park Y
    Amino Acids; 2011 Jan; 40(1):183-95. PubMed ID: 20512598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probing the "charge cluster mechanism" in amphipathic helical cationic antimicrobial peptides.
    Epand RF; Maloy WL; Ramamoorthy A; Epand RM
    Biochemistry; 2010 May; 49(19):4076-84. PubMed ID: 20387900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial Peptide Potency is Facilitated by Greater Conformational Flexibility when Binding to Gram-negative Bacterial Inner Membranes.
    Amos ST; Vermeer LS; Ferguson PM; Kozlowska J; Davy M; Bui TT; Drake AF; Lorenz CD; Mason AJ
    Sci Rep; 2016 Nov; 6():37639. PubMed ID: 27874065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of antibacterial action of dermaseptin B2: interplay between helix-hinge-helix structure and membrane curvature strain.
    Galanth C; Abbassi F; Lequin O; Ayala-Sanmartin J; Ladram A; Nicolas P; Amiche M
    Biochemistry; 2009 Jan; 48(2):313-27. PubMed ID: 19113844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane interactions of designed cationic antimicrobial peptides: the two thresholds.
    Glukhov E; Burrows LL; Deber CM
    Biopolymers; 2008 May; 89(5):360-71. PubMed ID: 18186149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective toxicity of antimicrobial peptide S-thanatin on bacteria.
    Wu G; Wu H; Fan X; Zhao R; Li X; Wang S; Ma Y; Shen Z; Xi T
    Peptides; 2010 Sep; 31(9):1669-73. PubMed ID: 20600431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using liquid crystals to report molecular interactions between cationic antimicrobial peptides and lipid membranes.
    Hu QZ; Jang CH
    Analyst; 2012 Feb; 137(3):567-70. PubMed ID: 22108758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solution structure and membrane interactions of the antimicrobial peptide fallaxidin 4.1a: an NMR and QCM study.
    Sherman PJ; Jackway RJ; Gehman JD; Praporski S; McCubbin GA; Mechler A; Martin LL; Separovic F; Bowie JH
    Biochemistry; 2009 Dec; 48(50):11892-901. PubMed ID: 19894755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid clustering by three homologous arginine-rich antimicrobial peptides is insensitive to amino acid arrangement and induced secondary structure.
    Epand RM; Epand RF; Arnusch CJ; Papahadjopoulos-Sternberg B; Wang G; Shai Y
    Biochim Biophys Acta; 2010 Jun; 1798(6):1272-80. PubMed ID: 20302840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of antimicrobial peptides on the bacterial membrane curvature and vice versa.
    Cardoso MH; de la Fuente-Nunez C; Santos NC; Zasloff MA; Franco OL
    Trends Microbiol; 2024 Jul; 32(7):624-627. PubMed ID: 38777700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modifications on amphiphilicity and cationicity of unnatural amino acid containing peptides for the improvement of antimicrobial activity against pathogenic bacteria.
    Taira J; Kida Y; Yamaguchi H; Kuwano K; Higashimoto Y; Kodama H
    J Pept Sci; 2010 Nov; 16(11):607-12. PubMed ID: 20648478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic antimicrobial oligomers induce a composition-dependent topological transition in membranes.
    Yang L; Gordon VD; Mishra A; Som A; Purdy KR; Davis MA; Tew GN; Wong GC
    J Am Chem Soc; 2007 Oct; 129(40):12141-7. PubMed ID: 17880067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Theoretical insight into the relationship between the structures of antimicrobial peptides and their actions on bacterial membranes.
    Chen L; Li X; Gao L; Fang W
    J Phys Chem B; 2015 Jan; 119(3):850-60. PubMed ID: 25062757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anionic Lipid Clustering Model.
    Epand RM
    Adv Exp Med Biol; 2019; 1117():65-71. PubMed ID: 30980353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides.
    Tsai CW; Hsu NY; Wang CH; Lu CY; Chang Y; Tsai HH; Ruaan RC
    J Mol Biol; 2009 Sep; 392(3):837-54. PubMed ID: 19576903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of antimicrobial peptide action: studies of indolicidin assembly at model membrane interfaces by in situ atomic force microscopy.
    Shaw JE; Alattia JR; Verity JE; Privé GG; Yip CM
    J Struct Biol; 2006 Apr; 154(1):42-58. PubMed ID: 16459101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial membranes as predictors of antimicrobial potency.
    Epand RM; Rotem S; Mor A; Berno B; Epand RF
    J Am Chem Soc; 2008 Oct; 130(43):14346-52. PubMed ID: 18826221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the central L- or D-Pro residue on structure and mode of action of a cell-selective alpha-helical IsCT-derived antimicrobial peptide.
    Lim SS; Kim Y; Park Y; Kim JI; Park IS; Hahm KS; Shin SY
    Biochem Biophys Res Commun; 2005 Sep; 334(4):1329-35. PubMed ID: 16040002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics.
    Lohner K; Blondelle SE
    Comb Chem High Throughput Screen; 2005 May; 8(3):241-56. PubMed ID: 15892626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
    Brogden KA
    Nat Rev Microbiol; 2005 Mar; 3(3):238-50. PubMed ID: 15703760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.